The observations are consistent with reports that decreased expression of cyclin B1 and BubR1 is associated with weakened spindle checkpoint and paclitaxel resistance in ovarian carcinoma cells [51]; depletion of BubR1 with siRNA resulted in loss of spindle assembly checkpoint function and resistance to paclitaxel [52]. Here, CCNB1 is linked to ovarian carcinoma.